| |
| |
| Exchange: |
OTC Bulletin Board |
| Security
Type: |
Common |
| Shares
Out: |
13,640,000 |
| Market
Cap: |
10.78(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.79 - $0.79 |
|
| Level
I Sector: |
Industrials |
| Level
II Sector: |
Diversified Services |
| Level
III Sector: |
Business Services |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Sonnet BioTherapeutics Holdings is a clinical-stage biopharmaceutical company with a proprietary technology for developing biologic medicines it refers to as FHAB (Fully Human Albumin Binding). Co. has a pipeline of therapeutic compounds focused primarily on oncology indications of unmet medical need, including SON-080, a low-dose formulation of Interleukin 6 which is in development for Chemotherapy Induced Peripheral Neuropathy; SON-1010, which is being developed for solid tumor indications, including non-small cell lung cancer and head and neck cancer, as well as for antiviral applications; and SON-1210, which is being developed for solid tumor indications, including colorectal cancer.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
479,855 |
539,855 |
| Total Buy Value |
$0 |
$0 |
$106,550 |
$141,650 |
| Total People Bought |
0 |
0 |
5 |
5 |
| Total Buy Transactions |
0 |
0 |
6 |
7 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Kraut Gregory Evan |
Director |
– • – |
2017-06-05 |
4 |
A |
$3.06 |
$2,047 |
D/D |
669 |
25,331 |
|
- |
|
| Kraut Gregory Evan |
Director |
– • – |
2017-06-05 |
4 |
B |
$2.63 |
$6,594 |
D/D |
2,500 |
24,662 |
2.39 |
- |
|
| Pruitt Michael |
CEO, Chairman |
• • – |
2017-06-02 |
4 |
B |
$2.76 |
$276 |
I/I |
100 |
1,520 |
2.58 |
- |
|
| Kraut Gregory Evan |
Director |
– • – |
2017-05-24 |
4 |
B |
$2.85 |
$8,550 |
D/D |
3,000 |
22,162 |
2.39 |
- |
|
| Pruitt Michael |
CEO, Chairman |
• • – |
2017-05-17 |
4 |
B |
$0.34 |
$1,699 |
I/I |
5,000 |
14,200 |
2.58 |
- |
|
| Kraut Gregory Evan |
Director |
– • – |
2017-04-21 |
4 |
A |
$2.38 |
$150 |
D/D |
63 |
25,394 |
|
- |
|
| Kraut Gregory Evan |
Director |
– • – |
2017-03-31 |
4 |
B |
$0.36 |
$1,800 |
D/D |
5,000 |
191,623 |
2.31 |
- |
|
| Pruitt Michael |
CEO, Chairman |
• • – |
2017-03-31 |
4 |
B |
$0.37 |
$1,104 |
I/I |
3,000 |
11,200 |
2.58 |
- |
|
| Kiefer Neil G |
Director |
– • – |
2017-01-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,000 |
|
- |
|
| Pruitt Michael |
CEO, Chairman |
• • – |
2017-01-03 |
4 |
B |
$0.40 |
$120 |
I/I |
300 |
8,200 |
2.58 |
- |
|
| Pruitt Michael |
CEO, Chairman |
• • – |
2016-12-29 |
4 |
B |
$0.43 |
$129 |
I/I |
300 |
7,900 |
2.58 |
- |
|
| Roberson Mark Daniel |
Chief Operating Officer |
• – – |
2016-12-28 |
4 |
B |
$13.50 |
$1,350 |
D/D |
100 |
100 |
2.66 |
- |
|
| Kraut Gregory Evan |
Director |
– • – |
2016-12-21 |
4 |
B |
$13.50 |
$4,050 |
D/D |
300 |
300 |
2.31 |
- |
|
| Pruitt Michael |
CEO, Chairman |
• • – |
2016-12-21 |
4 |
B |
$13.50 |
$1,350 |
I/I |
100 |
100 |
2.58 |
- |
|
| Roberson Mark Daniel |
Chief Operating Officer |
• – – |
2016-12-20 |
4 |
B |
$0.43 |
$860 |
D/D |
2,000 |
16,663 |
2.66 |
- |
|
| Kraut Gregory Evan |
Director |
– • – |
2016-12-16 |
4 |
B |
$0.42 |
$840 |
D/D |
2,000 |
186,623 |
2.31 |
- |
|
| Pruitt Michael |
CEO, Chairman |
• • – |
2016-11-28 |
4 |
B |
$0.54 |
$217 |
I/I |
400 |
7,600 |
2.58 |
- |
|
| Pruitt Michael |
CEO, Chairman |
• • – |
2016-11-16 |
4 |
B |
$0.55 |
$548 |
I/I |
1,000 |
7,200 |
2.58 |
- |
|
| Kraut Gregory Evan |
Director |
– • – |
2016-11-11 |
4 |
B |
$0.48 |
$960 |
D/D |
2,000 |
184,623 |
2.31 |
- |
|
| Kraut Gregory Evan |
Director |
– • – |
2016-09-28 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
175,623 |
|
- |
|
| Kraut Gregory Evan |
Director |
– • – |
2016-09-28 |
4 |
B |
$0.56 |
$3,919 |
D/D |
7,000 |
182,623 |
2.31 |
- |
|
| Pruitt Michael |
CEO, Chairman |
• • – |
2016-09-28 |
4 |
B |
$0.58 |
$232 |
I/I |
400 |
6,200 |
2.58 |
- |
|
| Carroll Mike |
Director |
– • – |
2016-09-23 |
4 |
B |
$0.63 |
$2,520 |
D/D |
4,000 |
20,500 |
2.31 |
- |
|
| Pruitt Michael |
CEO, Chairman |
• • – |
2016-09-15 |
4 |
B |
$0.58 |
$467 |
I/I |
800 |
5,800 |
2.58 |
- |
|
| Pruitt Michael |
CEO, Chairman |
• • – |
2016-09-07 |
4 |
B |
$0.41 |
$205 |
I/I |
500 |
5,000 |
2.58 |
- |
|
168 Records found
|
|
Page 6 of 7 |
|
|
